We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Follow‐up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: impact on allogeneic haematopoietic stem cell transplantation.
- Authors
Ishida, Takashi; Jo, Tatsuro; Takemoto, Shigeki; Suzushima, Hitoshi; Suehiro, Youko; Choi, Ilseung; Yoshimitsu, Makoto; Saburi, Yoshio; Nosaka, Kisato; Utsunomiya, Atae; Kobayashi, Yukio; Yamamoto, Kazuhito; Fujiwara, Hiroshi; Ishitsuka, Kenji; Yoshida, Shinichiro; Taira, Naoya; Imada, Kazunori; Kato, Koji; Moriuchi, Yukiyoshi; Yoshimura, Kenichi
- Abstract
The article informs on a phase II study conducted for evaluating whether the addition of mogamulizumab, a defucosylated humanised anti-CCR4 antibody, to mLSG15 increases efficacy in patients with newly-diagnosed aggressive adult T cell leukaemia-lymphoma (ATL). It examines its impact on allogeneic haematopoietic stem cell transplantation; and no differences were found in the survival between the mLSG15+mogamulizumab and mLSG15 arms in patients with newly diagnosed aggressive ATL.
- Publication
British Journal of Haematology, 2019, Vol 184, Issue 3, p479
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.15123